MedTrace Logo

A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women

NCT06983925 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-08-08

No results posted yet for this study

Summary

To evaluate the pharmacokinetic (PK) characteristics of GS1-144 tablets and the relative bioavailability of the two preparations in healthy postmenopausal female subjects in China.

Conditions

  • Healthy Postmenopausal Women

Interventions

DRUG

GS1-144 Tablet with new preparation (T)

GS1-144 Tablet with new preparation (T)

DRUG

GS1-144 Tablet with present preparation (R)

A single oral dose of GS1-144 Tablet with present preparation

Sponsors & Collaborators

  • Changchun GeneScience Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2025-07-14
Completion
2025-07-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06983925 on ClinicalTrials.gov